Pay in 4 interest-free payments of $7.24 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
Recently, a phase II multicentre, double-blind, randomized controlled trial including 338 adults with obesity were administered retatrutide (1, 2 mg starting dose increased to 4, 2 mg starting dose increased to 8, 2 mg starting dose increased to 12 mg) compared to placebo over 48 weeks [64]
Figure: Graph showing the risk of SIBO with different GLP-RA agents Figure: Table showing the risk of SIBO with different GLP-1 RA agents Disclosures: Lina AlQirem indicated no relevant financial relationships
Some customers report minor appetite changes or energy boosts, but many notice no difference at all
Nearly 72% of the posts mentioned reduced cravings, less drinking, and other effects related to drinking while taking the drugs, researchers said
